Next Article in Journal
Impaired Performance of Broiler Chickens Fed Diets Naturally Contaminated with Moderate Levels of Deoxynivalenol
Next Article in Special Issue
Botulinum Toxin Type-A (Botulax®) Treatment in Patients with Intractable Chronic Occipital Neuralgia: A Pilot Study
Previous Article in Journal
Shellfish Toxin Uptake and Depuration in Multiple Atlantic Canadian Molluscan Species: Application to Selection of Sentinel Species in Monitoring Programs
Previous Article in Special Issue
Ultrasonographic Considerations for Safe and Efficient Botulinum Neurotoxin Injection in Masseteric Hypertrophy
Open AccessReview

Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review

1
College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, UAE
2
Riekie Smit Practice, Pretoria 0182, South Africa
3
Ipsen Pharmaceutical, 92100 Boulogne-Billancourt, France
4
Visconti di Modrone Medical Center, 20122 Milan, Italy
*
Author to whom correspondence should be addressed.
Received: 18 January 2021 / Revised: 9 February 2021 / Accepted: 15 February 2021 / Published: 22 February 2021
(This article belongs to the Special Issue Application of Botulinum Toxin in Clinical Medicine)
AbobotulinumtoxinA (aboBoNT-A) has been used for various cosmetic purposes, including minimization of moderate to severe lines, or other cosmetic indications, in the face and neck. We carried out a systematic review to identify all relevant evidence on the treatment approaches and outcomes of aboBoNT-A as a cosmetic treatment of the middle and lower areas of the face, and the neck. Embase, MEDLINE, Cochrane Library, congress proceedings and review bibliographies were searched for relevant studies. Identified articles were screened against pre-specified eligibility criteria. Of 560 unique articles identified, 10 were included for data extraction (three observational studies, 1 randomized controlled trial [with two articles] and five non-randomized trials). The articles provided data on gummy/asymmetric smile (2), marionette lines (5), masseter muscle volume (2), nasal wrinkles (2), perioral wrinkles (3) and the platysma muscle (4). All articles reporting on efficacy of aboBoNT-A demonstrated positive results, including reduction of wrinkles (5), reduction of masseter muscle (2) and degree of gummy smile (1) compared with before treatment. No serious adverse events were reported and patient satisfaction was high. In conclusion, positive findings support further research of aboBoNT-A for the middle and lower areas of the face, and in the neck, which are largely unapproved indications. View Full-Text
Keywords: abobotulinumtoxinA; botulinum toxin; lower face; marionette lines; masseter; neck; perioral area; platysma; middle face abobotulinumtoxinA; botulinum toxin; lower face; marionette lines; masseter; neck; perioral area; platysma; middle face
Show Figures

Figure 1

MDPI and ACS Style

Galadari, H.; Galadari, I.; Smit, R.; Prygova, I.; Redaelli, A. Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review. Toxins 2021, 13, 169. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins13020169

AMA Style

Galadari H, Galadari I, Smit R, Prygova I, Redaelli A. Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review. Toxins. 2021; 13(2):169. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins13020169

Chicago/Turabian Style

Galadari, Hassan; Galadari, Ibrahim; Smit, Riekie; Prygova, Inna; Redaelli, Alessio. 2021. "Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review" Toxins 13, no. 2: 169. https://0-doi-org.brum.beds.ac.uk/10.3390/toxins13020169

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop